Key result
Derapril, but not manidipine, significantly improved baroreceptor sensitivity (from 5.0 to 5.6 msec/mm Hg) and carotid arterial distensibility (from 2.1 to 2.5 %kPa) in hypertensive patients.
Why the study?
Does derapril improve cardiovascular autonomic nervous system function and carotid distensibility compared to manidipine in patients with mild to moderate hypertension?
RCT (n=37)
randomly allocated
Does derapril improve cardiovascular autonomic nervous system function and carotid distensibility compared to manidipine in patients with mild to moderate hypertension?
Answers are grounded in this paper and cite their sources.
The ACE inhibitor derapril, but not the calcium channel blocker manidipine, improved autonomic balance and carotid distensibility in hypertensive patients, suggesting vascular benefits beyond blood pressure lowering.
We investigated the relationship between cardiovascular autonomic nervous system function and carotid arterial distensibility during treatment with an angiotensin converting enzyme inhibitor (derapril) or a calcium channel blocker (manidipine) for hypertension. In 37 patients with hypertension, autonomic function was assessed by heart rate variability and baroreceptor sensitivity using phenylephrine injection. Left ventricular mass index and carotid arterial distensibility were assessed by ultrasound examinations. Before the medication, both baroreceptor sensitivity and heart rate variability correlated with carotid arterial distensibility, but not with left ventricular mass index by multiple regression analysis. Subsequently, patients were randomly allocated into two groups, derapril (n = 18) and manidipine (n = 19) for 20 weeks. At the end of the study, the change in baroreceptor sensitivity correlated with change in carotid arterial distensibility (r = 0.41, P < .05), but not with change in left ventricular mass index. Although derapril and manidipine decreased blood pressure and left ventricular mass index to the same extent, the former improved heart rate variability, baroreceptor sensitivity (5.0 +/- 1.9 --> 5.6 +/- 2.0 msec/mm Hg), and carotid arterial distensibility (2.1 +/- 0.8 --> 2.5 +/- 1.0 %kPa), but the latter did not improve them at all. Thus, impairment of the autonomic balance was related to the impairment of carotid arterial distensibility in hypertension; derapril, but not manidipine, significantly improved these abnormalities.
No takes yet. Share an insight, caveat, or question.
Tomiyama et al. (1998) conducted an RCT in Mild to moderate hypertension (n=37). Derapril vs. Manidipine was evaluated on Baroreceptor sensitivity and carotid arterial distensibility. Derapril, but not manidipine, significantly improved baroreceptor sensitivity (from 5.0 to 5.6 msec/mm Hg) and carotid arterial distensibility (from 2.1 to 2.5 %kPa) in hypertensive patients.
Synapse has enriched 10 related papers. Consider them for comparative context: